Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01443026 · ClinicalTrials.gov registry record · Phase 2
The Effects of Lycopene on High Risk Prostatic Tissue
A Phase 2 study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT01443026 is a Phase 2 study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 66 participants.
The verdict
NCT01443026, a Phase 2 study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare the effects of a lycopene supplement made from tomatoes to a placebo (a capsule with no active ingredients) in men who have abnormal cells in the prostate, but have not yet had cancer detected. This study will allow us to see if taking lycopene for six months leads to favorable changes in abnormal prostate tissue and in chemicals measured in the blood that go along with a higher risk of developing cancer.
Interventions
- DRUG Placebo
- DRUG Lycopene 30mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01443026
The ClinicalTrials.gov registry entry for NCT01443026 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01443026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01443026 about?
NCT01443026 is a clinical study titled "The Effects of Lycopene on High Risk Prostatic Tissue". The purpose of this research study is to compare the effects of a lycopene supplement made from tomatoes to a placebo (a capsule with no active ingredients) in men who have abnormal cells in the prostate, but have not yet had cancer detected. This study will allow us to see if taking lycopene for si...
What is the current status of trial NCT01443026?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2006-02. Estimated completion is 2009-04.
What interventions are being tested in trial NCT01443026?
The interventions under investigation include: Placebo (DRUG), Lycopene 30mg (DRUG).
Who is sponsoring clinical trial NCT01443026?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.